METHODS We conducted a systematic study which represents one of the most
comprehensive effort to quantify global HCV epidemiology, using the best available …

The treatment of chronic hepatitis C virus (HCV) infection has the potential to change
significantly over the next few years as therapeutic regimens are rapidly evolving. However …

In efforts to inform public health decision makers, the Global Burden of Diseases, Injuries,
and Risk Factors 2010 (GBD2010) Study aims to estimate the burden of disease using …

Abstract Worldwide, an estimated 130–170 million people have HCV infection. HCV
prevalence is highest in Egypt at> 10% of the general population and China has the most …

Conclusion: HBV-induced HCC is a complex, stepwise process that includes integration of
HBV DNA into host DNA at multiple or single sites. On the contrary, the cancerogenesis …

More than 20 years after the discovery of the hepatitis C virus (HCV), it is now well
established that HCV is of global importance affecting all countries, leading to a major global …

ISOLATED ALTERATIONS OF BIOCHEMICAL MARKERS OF LIVER DAMAGE in a
seemingly healthy patient can present a challenge for the clinician. In this review we provide …

BACKGROUND/AIMS: End-stage liver disease accounts for one in forty deaths worldwide.
Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are well …

Hepatitis C is of concern both to industrialized and developing countries. Preliminary
unpublished estimates of the global burden of disease (GBD) attributable to HCV‐related …

People detained in prisons and other closed settings are at elevated risk of infection with
hepatitis C virus (HCV). We undertook a systematic review and meta‐analysis with the aim …